Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Antares Vision SpA ( (IT:AV) ) has provided an update.
Antares Vision Group is partnering with Guinea-Bissau to advance the digital transformation of its national health system, focusing on pharmaceutical traceability and safety. This collaboration aims to establish a digital healthcare ecosystem in West Africa, enhancing transparency and reliability in the pharmaceutical supply chain, and potentially setting a new standard for the region.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.00 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
More about Antares Vision SpA
Antares Vision Group is an Italian multinational specializing in product safety and supply chain transparency through innovative technologies for quality control, traceability, and data management. The company operates in the Life Science, Cosmetics, and FMCG sectors, supporting digitalization for improved sustainability and efficiency. It is a leader in drug traceability, serving major global producers and government authorities, with a presence in over 60 countries.
Average Trading Volume: 112,603
Technical Sentiment Signal: Buy
Current Market Cap: €297.2M
See more data about AV stock on TipRanks’ Stock Analysis page.